Vanina de Verneuil, EVP and General Counsel at Vir Biotechnology, Inc. (VIR), sold 4,397 shares at $10.11 ($44K) on 2024-11-06, disclosed to the SEC on 2024-11-07.
Scheduled sale ($44k) by EVP and General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2025-11-07 | $12K | — | Filing → |
| VIR | SELL | 2025-11-04 | $8K | — | Filing → |
| VIR | SELL | 2025-02-27 | $135K | — | Filing → |